EQS-NVR: Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


Werte in diesem Artikel

EQS Total Voting Rights Announcement: Epigenomics AG / Total Voting Rights Announcement
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18.07.2024 / 13:24 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer
Epigenomics AG
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany

2. Type of capital measure or other measure
  Type of capital measure or other measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 17.07.2024
  Other (capital) measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
876.949
number of multiple voting rights thereof: 0



18.07.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Epigenomics AG
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany
Internet: www.epigenomics.com

 
End of News EQS News Service

Werbung

1947417  18.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1947417&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6
Werbung

Epigenomics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Epigenomics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.